COMMUNIQUÉS West-GlobeNewswire

STERIS Announces Financial Results for Fiscal 2026 First Quarter
06/08/2025
Total revenue from continuing operations increased 9%; constant currency organic revenue grew 8% As reported EPS from continuing operations increased to $1.79; adjusted EPS increased to $2.34 Fiscal 2026 revenue and [...]
Tenaya Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
06/08/2025
Enrollment Complete in Cohorts 1 and 2 of MyPEAK™ -1 Phase 1b/2 Trial of TN-201 for MYBPC3-associated HCM; Positive DSMB Safety Review Enables Enrollment of Expansion Cohorts Cohort 1 of RIDGE™-1 Phase 1b Trial of TN- [...]
Surrozen to Present at Upcoming Healthcare Investor Conference
06/08/2025
SOUTH SAN FRANCISCO, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt [...]
Aptose Enrollment is Open for 160 mg Dosing Cohort of Tuspetinib in Phase 1/2 TUSCANY Trial of Frontline Triple Drug Therapy
06/08/2025
Safety Review Committee endorses escalation to 160 mg TUS dosing Cohorts with 120 mg, 80 mg, 40 mg TUS dosing completed with no dose-limiting toxicities Excellent safety and complete remissions (CRs) in some of the most [...]
BioAge Labs Reports Second Quarter 2025 Financial Results and Provides Business Updates
06/08/2025
Oral NLRP3 inhibitor BGE-102 on track for Phase 1 initiation in 2H 2025 with initial data by year-end Expanded APJ agonist pipeline through option agreement for novel antibody and advancement of proprietary oral small [...]
STERIS Announces Chief Financial Officer Transition
06/08/2025
Long-time CFO Michael J. Tokich to be succeeded by Karen L. Burton, Chief Accounting Officer DUBLIN, IRELAND, Aug. 06, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that [...]
Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
06/08/2025
SEATTLE, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has commenced an [...]
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
06/08/2025
MALVERN, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life [...]
Cannabis: The Gateway to Tomatoes? New Survey Says Yes
06/08/2025
Homegrown Cannabis Co. study reveals most cannabis growers eventually become home vegetable gardeners FORT LAUDERDALE, Fla., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Cannabis isn’t just transforming laws and lifestyles but [...]
Extendicare Announces 2025 Second Quarter Results
06/08/2025
MARKHAM, Ontario, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and six months ended June 30, 2025. Second Quarter 2025 Highlights [...]
NADP Foundation Issues Request for Proposals
06/08/2025
DALLAS, Aug. 06, 2025 (GLOBE NEWSWIRE) -- To solicit projects advancing access to oral health care, the National Association of Dental Plans (NADP) Foundation issued its 2025 request for proposal (RFP) on Aug. 1. The [...]
Immix Biopharma Announces Other Serious Diseases Strategy
06/08/2025
– Dosing ongoing and planned in a handful of Other Serious Diseases (OSD) – – Company plans to partner-out Other Serious Disease programs – – On track for first Biologics License Application (BLA) approved cell therapy [...]
ONWARD Medical annonce la nomination de Lucas Buchanan à son conseil d’administration
06/08/2025
M. Buchanan est l’ancien directeur financier et directeur des opérations de Silk Road Medical, où il a développé avec succès une entreprise de dispositifs médicaux en phase de croissance, aboutissant à son acquisition [...]
Lambert Eaton Myasthenic Syndrome (LEMS) Antibody Testing and Treatment Recommendations Added to NCCN Clinical Practice Guidelines for Small Cell Lung Cancer (SCLC)
06/08/2025
VGCC antibody testing in conjunction with neurologic consultation can diagnose LEMS Amifampridine may be considered as a supportive care treatment Guideline inclusion may raise clinical awareness of cancer-associated [...]
Profusa, Inc. Provides Strategy Overview and Business Update for Investors
06/08/2025
BERKELEY, Calif, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the [...]
Lung Health Foundation Encouraged by Ontario’s $1.8 Billion Primary Care Investment and Hopes Vital Respiratory Services Will Be Included
06/08/2025
LHF points to proven success of provincial Primary Care Asthma and COPD Program (PCAP) clinics in cutting emergency department visits and hospitalizations by 80% TORONTO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- As Ontario [...]
Milestone Scientific Appoints Jason Papes as Senior Vice President, Global Head of Sales and Marketing
06/08/2025
Brings over 30 years of experience in scaling commercial operations across healthcare and medical technology sectors ROSELAND. N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading [...]
Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology
06/08/2025
Experienced cardiac electrophysiologist joins Glucotrack’s growing clinical advisory team as the Company advances its long-term CBGM through critical clinical milestones RUTHERFORD, N.J., Aug. 06, 2025 (GLOBE NEWSWIRE [...]
RenovoRx Expands U.S. Commercialization Efforts for the RenovoCath® Device with Growing Customer Demand and Key Leadership Hire
06/08/2025
RenovoRx increases its commercial footprint to thirteen leading National Cancer Institute-designated and community centers approved to purchase RenovoCath Four active cancer center customers are currently purchasing and [...]

Pages